"Convalescent Plasma Is Safe to Treat Covid-19, National Study Shows" - Amy Dockser Marcus

Mount Sinai Health System Hospitals Recognized Among World’s Best and No. 1 in Newsweek/Statista Rankings

Mount Sinai Awarded $2 Million to Launch International Clinical Trial on Spontaneous Coronary Artery Dissection

People With Long COVID Who Used a Noninvasive Magnetic Therapy Headset Show Improved Cognitive Function and Mood

Mount Sinai Researcher Appointed to National Academies Committee Examining Neurocognitive Effects of SARS-CoV-2 Across the Lifespan

Monoclonal Antibody Targeting Interleukin-6 Achieves Sustained Reductions in Inflammation Biomarkers Through Six Months

The Ross Procedure Is Associated With Excellent Outcomes, Durability, and Efficacy in a Wide Range of Adults With Aortic Valve Disease

Healthy Sleep and Regular Exercise Can Mitigate the Genetic Cardiovascular Risk of Mutant White Blood Cells

Mount Sinai Scientists Validate a Link Between Autoimmunity in a Subset of People With Long COVID

Mount Sinai Researchers Develop Machine Learning Model to Predict How CPAP Affects Cardiovascular Disease Risk in Patients With Obstructive Sleep Apnea

Mount Sinai Launches Adams Valve Institute, Specializing in Complex Valve Surgery and Valvular Heart Disease

Nearly 30 Percent of Patients With Resistant Hypertension Have a Hormone Disorder Caused by High Cortisol